Physician profile
Darcy Putz
NPI 1821058033
$183.15
in general payments reported to CMS, 2019-2025
8 companies · $54.01 in 2025
The $54.01 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.56 · 2020: $11.83 · 2021: $27.15 · 2022: $28.14 · 2023: $47.46 · 2025: $54.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $101.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $53.87 | 2021-2023 | Freestyle Libre 3 |
| Novo Nordisk INC | $34.26 | 2022-2023 | Rybelsus, Ozempic |
| Radius Health, INC. | $19.16 | 2025 | |
| Dynavax Technologies Corporation | $17.90 | 2025 | Heplisav-B |
| Dexcom, INC. | $16.95 | 2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.62 | 2023 | Jardiance |
| Janssen Pharmaceuticals, INC | $14.56 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darcy Putz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.